| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:50 UTC |
|---|
| HMDB ID | HMDB0015048 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Repaglinide |
|---|
| Description | Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to cells of the pancreas to stimulate insulin release. Repaglinide induces an early insulin response to meals decreasing postprandial blood glucose levels. It should only be taken with meals and meal-time doses should be skipped with any skipped meal. Approximately one month of therapy is required before a decrease in fasting blood glucose is seen. Meglitnides may have a neutral effect on weight or cause a slight increase in weight. The average weight gain caused by meglitinides appears to be lower than that caused by sulfonylureas and insulin and appears to occur only in those naive to oral antidiabetic agents. Due to their mechanism of action, meglitinides may cause hypoglycemia although the risk is thought to be lower than that of sulfonylureas since their action is dependent on the presence of glucose. In addition to reducing postprandial and fasting blood glucose, meglitnides have been shown to decrease glycosylated hemoglobin (HbA1c) levels, which are reflective of the last 8-10 weeks of glucose control. Meglitinides appear to be more effective at lowering postprandial blood glucose than metformin, sulfonylureas and thiazolidinediones. Repaglinide is extensively metabolized in the liver and excreted in bile. Repaglinide metabolites do not possess appreciable hypoglycemic activity. Approximately 90% of a single orally administered dose is eliminated in feces and 8% in urine. |
|---|
| Structure | CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Prandin | Kegg | | Surepost | Kegg | | AG-ee 388 ZW | HMDB | | AG-ee 623 ZW | HMDB | | Glaxo wellcome brand OF replaginide | HMDB | | Novo nordisk brand 2 OF repaglinide | HMDB | | Repa-glinide | HMDB | | 2-Ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid | HMDB | | Novo nordisk brand OF repaglinide | HMDB | | NovoNorm | HMDB | | Repaglinide, (+-)-isomer | HMDB | | 2-Ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid | HMDB | | AG-ee 388 | HMDB | | GlucoNorm | HMDB |
|
|---|
| Chemical Formula | C27H36N2O4 |
|---|
| Average Molecular Weight | 452.5857 |
|---|
| Monoisotopic Molecular Weight | 452.26750765 |
|---|
| IUPAC Name | 2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid |
|---|
| Traditional Name | repaglinide |
|---|
| CAS Registry Number | 135062-02-1 |
|---|
| SMILES | CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1 |
|---|
| InChI Key | FAEKWTJYAYMJKF-QHCPKHFHSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylpiperidines. Phenylpiperidines are compounds containing a phenylpiperidine skeleton, which consists of a piperidine bound to a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Piperidines |
|---|
| Sub Class | Phenylpiperidines |
|---|
| Direct Parent | Phenylpiperidines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenylpiperidine
- Phenylacetamide
- Benzoic acid or derivatives
- Benzoic acid
- Phenoxy compound
- Benzoyl
- Phenol ether
- Tertiary aliphatic/aromatic amine
- Dialkylarylamine
- Aniline or substituted anilines
- Alkyl aryl ether
- Benzenoid
- Monocyclic benzene moiety
- Amino acid
- Tertiary amine
- Carboxamide group
- Amino acid or derivatives
- Secondary carboxylic acid amide
- Monocarboxylic acid or derivatives
- Ether
- Carboxylic acid
- Carboxylic acid derivative
- Azacycle
- Organonitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Amine
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 130 - 131 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0029 g/L | Not Available | | LogP | 5.9 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.41 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 18.5492 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.07 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 34.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3073.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 326.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 244.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 187.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 171.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 847.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 737.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 85.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1646.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 649.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1856.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 500.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 483.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 201.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 254.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Repaglinide,1TMS,isomer #1 | CCOC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O[Si](C)(C)C | 3477.8 | Semi standard non polar | 33892256 | | Repaglinide,1TMS,isomer #2 | CCOC1=CC(CC(=O)N([C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)[Si](C)(C)C)=CC=C1C(=O)O | 3473.2 | Semi standard non polar | 33892256 | | Repaglinide,2TMS,isomer #1 | CCOC1=CC(CC(=O)N([C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)[Si](C)(C)C)=CC=C1C(=O)O[Si](C)(C)C | 3422.4 | Semi standard non polar | 33892256 | | Repaglinide,2TMS,isomer #1 | CCOC1=CC(CC(=O)N([C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)[Si](C)(C)C)=CC=C1C(=O)O[Si](C)(C)C | 3250.9 | Standard non polar | 33892256 | | Repaglinide,2TMS,isomer #1 | CCOC1=CC(CC(=O)N([C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)[Si](C)(C)C)=CC=C1C(=O)O[Si](C)(C)C | 4117.6 | Standard polar | 33892256 | | Repaglinide,1TBDMS,isomer #1 | CCOC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 3702.1 | Semi standard non polar | 33892256 | | Repaglinide,1TBDMS,isomer #2 | CCOC1=CC(CC(=O)N([C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O | 3675.2 | Semi standard non polar | 33892256 | | Repaglinide,2TBDMS,isomer #1 | CCOC1=CC(CC(=O)N([C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 3794.4 | Semi standard non polar | 33892256 | | Repaglinide,2TBDMS,isomer #1 | CCOC1=CC(CC(=O)N([C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 3577.9 | Standard non polar | 33892256 | | Repaglinide,2TBDMS,isomer #1 | CCOC1=CC(CC(=O)N([C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 4224.2 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Repaglinide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0g7j-2958400000-8cbddf3d4598a0fc7340 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Repaglinide GC-MS (1 TMS) - 70eV, Positive | splash10-00ei-5260910000-4aaa7a93bda9f63c45e2 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Repaglinide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide LC-ESI-QTOF , negative-QTOF | splash10-0udi-0000900000-c0108433e6c3f3bf1c75 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide LC-ESI-QTOF , negative-QTOF | splash10-004i-0009000000-30aa31031f07d8ae52b8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide LC-ESI-QTOF , negative-QTOF | splash10-002r-0908000000-b76282b9697187110f0a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide LC-ESI-QTOF , positive-QTOF | splash10-0udi-0000900000-2f6de321d96a7df0cde9 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide LC-ESI-QTOF , positive-QTOF | splash10-0udi-0140900000-4fef8b8042e88aa84955 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide LC-ESI-QTOF , positive-QTOF | splash10-001i-0290000000-4867f74dff429e78bb45 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide LC-ESI-QTOF , positive-QTOF | splash10-001i-0290000000-bdb018b622ca04e9d8b1 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide LC-ESI-QTOF , positive-QTOF | splash10-001i-0590000000-60f613e4ee0d364efcea | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide , positive-QTOF | splash10-0f89-2791700000-333192fa8176a2febaa5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 20V, Positive-QTOF | splash10-0udi-0140900000-4fef8b8042e88aa84955 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 50V, Positive-QTOF | splash10-0089-0970000000-602d29c500b424ed363e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 20V, Negative-QTOF | splash10-004i-0009000000-30aa31031f07d8ae52b8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 10V, Positive-QTOF | splash10-0udi-0000900000-dee9fb6cd200b9ec5dea | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 30V, Positive-QTOF | splash10-001i-0290000000-eb9b8068f0e4a444f798 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 10V, Negative-QTOF | splash10-0udi-0000900000-c0108433e6c3f3bf1c75 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 30V, Negative-QTOF | splash10-002r-0908000000-b76282b9697187110f0a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 40V, Positive-QTOF | splash10-001i-0290000000-720a9142676a841f0079 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 20V, Positive-QTOF | splash10-0gx0-0590600000-eb3b3f1dce83738e96c9 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Repaglinide 10V, Positive-QTOF | splash10-0udi-0000900000-c946d573c5042841c3f6 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Repaglinide 10V, Positive-QTOF | splash10-0f6t-0181900000-f133163bc1e44e5ff6f3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Repaglinide 20V, Positive-QTOF | splash10-0002-1691100000-199236474a5fb7cb930d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Repaglinide 40V, Positive-QTOF | splash10-0a5a-4940000000-4dc08f986e76785388e2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Repaglinide 10V, Negative-QTOF | splash10-0zfr-0010900000-dd8d5e58d8cda3e20087 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Repaglinide 20V, Negative-QTOF | splash10-0bt9-1554900000-694c7b4171377cee14c4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Repaglinide 40V, Negative-QTOF | splash10-004i-2966000000-f2d3f7a4cbcb2910e30f | 2016-08-03 | Wishart Lab | View Spectrum |
|
|---|